Lopinavir/ritonavir

Developed for: HIV infectious disease
Investigated by: Guangdong Provincial Maternal and Child Health Hospital · Maternal and Child Health Hospital of Guangxi Province · Maternal and Child Health Hospital of Sichuan Province · Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region · Maternal and Child Health Hospital of Yunan Province · National Center for AIDS/STD Control and Prevention, China CDC
+1 more
· National Center for Women and Children's Health, China CDC

today NCT02712801 · Ph 4

201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02712801	Apr 2016 → Dec 2021	HIV infectious disease	National Center for Women and Children's Health, China CDC	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Lopinavir/ritonavir	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02712801 ↗